As part of its corporate social responsibility and in commemoration of this year’s World Malaria Day (WMD), Shalina Healthcare, one of the leading pharmaceutical companies in the country, has taken sensitisation campaign, as well as free healthcare screening to Lagos street sweepers, under the aegis of Lagos Waste Management Authority (LAWMA).
The programme, which was tagged “Knock Out Malaria in 3 Days” powered by Shal’Artem, held at LAWMA headquarters, Ijora Olopa, Lagos recently.
It had attendance in attendance members of Shalina management team, as well as healthcare experts which included, Mr Ayo Akinsola, training capacity development manager; Shalina Healthcare Nigeria; Dr Yetunde Oyalowo, founder, Market Doctors, and Mr Taiwo Oshinusi, director, Market Doctors, among others.
Disclosing this in a press release made available to Pharmanewsonline, Mr Chiuba Nwaosu, brand manager, Shal’Artem, said the World Malaria Day 2022 was marked under the theme “Harness innovation to reduce the malaria disease burden and save lives”. This theme by WHO admits to the fact that every effort counts and therefore sets the tone for this year’s “Knock Out Malaria in 3 Days”.
According to him, the #KnockOutMalariain3Days Campaign witnessed a 3-day nationwide effort to eliminate malaria from Nigeria, adding that the campaign was centred on three-pronged advocacy involving proper sanitation, education on prevention/testing and finally treatment with ACT.
“Over 5000 Nigerians were reached directly within 3 days with education to prevent malaria, gifts of mosquito treated nets, free testing with rapid diagnostic kits and free instant malaria consultation and treatment with Shal’Artem for those with positive test results. With this Shalina healthcare re-iterates its commitment to “doing its part” in curbing the menace of malaria by placing Nigeria back on a trajectory of achieving the 2030 targets of the WHO global malaria strategy,” he said.
“Thus, Shalina Healthcare’s venture at local manufacturing of pharmaceutical medicines through the establishment of a WHO state of the art manufacturing facility in Nigeria further speaks of its commitment to fulfilling its mission: quality, affordability and availability. Therefore, the company aims to make access to quality pharmaceutical medicines a right for all Africans”.